{"disease":{"id":"urothelial-bladder-cancer-nos","name":"urothelial bladder cancer nos"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03339843","title":"Multiorgan Metabolic Imaging Response Assessment of Abemaciclib","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT03359239","title":"Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Matthew Galsky","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}